Introduction
Injectable procedures using botulinum toxin and dermal fillers are widely performed, but they are not without risk. Even in experienced hands, adverse events can occur, and the ability to recognize and respond to them promptly is a defining feature of safe practice. This educational overview describes common and serious complications associated with injectables, the principles of early recognition, and the importance of preparedness. It also addresses, in clear terms, the scope limits that apply to dentists in Ontario.
Understanding the Spectrum of Adverse Events
Adverse events range from mild and self-limiting to rare but serious. Common, minor reactions include bruising, swelling, tenderness, and transient redness at the injection site. More significant complications can include infection, hypersensitivity reactions, nodules, or unintended spread of botulinum toxin leading to effects such as eyelid droop. The most serious filler complication is vascular occlusion, in which product compromises blood supply, potentially causing tissue loss or, very rarely, visual disturbance.
Recognizing these events depends on knowing what to expect and what is abnormal. Severe or disproportionate pain, blanching of the skin, a dusky or mottled appearance, or visual changes are warning signs that require immediate attention. Early recognition is the single greatest determinant of outcome in serious filler complications.
Timing also helps with recognition. Some reactions appear immediately, while others, such as delayed-onset nodules or late infection, may emerge days or weeks later. Giving clients clear aftercare information and a way to report concerns promptly extends the clinician's ability to catch problems early. A client who knows which symptoms warrant an urgent call becomes an active partner in their own safety rather than a passive recipient of care.
Prevention Through Assessment
Many adverse events are reduced by thorough pre-procedure assessment: a complete health history, identification of contraindications, and realistic expectation-setting. Knowledge of relevant anatomy and sound technique further lowers risk. Our article on managing patient expectations about cosmetic results discusses the communication side of this preparation.
Contraindications deserve particular care. Certain medical conditions, medications, pregnancy, active infection at the treatment site, and a history of hypersensitivity may make a procedure inadvisable. A structured intake that screens for these factors, combined with a willingness to decline or postpone when appropriate, prevents many complications before they can occur. Recognizing when a client is not a suitable candidate is as important a clinical judgement as any technique.
Principles of Management and Preparedness
Preparedness means having protocols, equipment, and training in place before an event occurs. Practitioners should understand escalation pathways, maintain emergency supplies appropriate to their procedures, and know when and how to seek urgent medical support. Clear documentation of the event, the response, and follow-up is essential and connects to broader record-keeping practice discussed in our overview of documentation and clinical photography in aesthetic practice.
Structured education helps professionals build this preparedness. For medical professionals pursuing injectable training, the complication-management component of the Botox and filler injectable training is a five-day course that covers contraindications and complication management alongside technique. A certificate from any such course documents training only; it is not a licence or permission to practise, and it does not expand the scope authorized by a professional's regulatory college.
Scope of Practice in Ontario
Scope is a critical consideration for anyone offering injectables, and the rules differ by profession. For Ontario dentists, the Royal College of Dental Surgeons of Ontario sets clear limits. Dentists may use botulinum toxin and dermal fillers only within the scope of dentistry. In practical terms, this means intra-oral therapeutic or cosmetic use, and the use of botulinum toxin extra-orally only for therapeutic purposes, such as the management of certain temporomandibular disorders. Extra-oral cosmetic use, for example treating facial lines purely for appearance, is not within the scope of dentistry in Ontario.
Nurses, nurse practitioners, and physicians are governed by their own bodies, the College of Nurses of Ontario and the College of Physicians and Surgeons of Ontario respectively, and their scope and delegation rules differ. Because requirements vary by profession and can change, every practitioner must verify with their own regulatory college what injectable activities they are permitted to perform before offering them, and our article on professional boundaries and scope of practice explores this further.
Conclusion
Safe injectable practice depends on anticipating adverse events, recognizing them early, and responding with prepared, well-documented protocols. Vascular occlusion in particular demands immediate recognition and action. Just as important as clinical skill is operating strictly within one's authorized scope; for Ontario dentists, that means respecting the RCDSO limits on extra-oral cosmetic use. Professionals should ground their practice in regulatory standards and confirm their permitted scope before undertaking any injectable procedure.
References
- Royal College of Dental Surgeons of Ontario. Guidance on the use of botulinum toxin and dermal fillers within the scope of dentistry. rcdso.org.
- College of Physicians and Surgeons of Ontario. Policy on cosmetic and injectable procedures. cpso.on.ca.
- College of Nurses of Ontario. Scope of practice and controlled acts guidance. cno.org.
- Health Canada. Safety information on botulinum toxin and dermal filler products. canada.ca.